Fundz

Neuro Sense Therapeutics Ltd reported raising $4.47 Million in an initial SEC Form D filing, from an offering of $4.47 Million

PUBLIC · NRSNApr 25, 2024

Amount Raised

$4.47 Million

$4.47 Million sold, per SEC Form D (first sale Apr 15, 2024)

Round Type

Seed

HerzliyaBiotechnology

Quick answer

NeuroSense Therapeutics raised $4.47 Million in a Seed round, dated April 15, 2024. NeuroSense Therapeutics is based in Herzliya, Tel Aviv, Israel.

How much did NeuroSense Therapeutics raise?
NeuroSense Therapeutics raised $4.47 Million in a Seed round on April 15, 2024.
What does NeuroSense Therapeutics do?
NeuroSense Therapeutics is a clinical-stage biopharmaceutical company, focusing on the discovery and development of targeted innovative therapeutics for neurodegenerative diseases.
Where is NeuroSense Therapeutics based and how big is it?
NeuroSense Therapeutics is based in Herzliya, Tel Aviv, Israel.
Who are the decision-makers at NeuroSense Therapeutics?
Fundz holds 1 contact at NeuroSense Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as NeuroSense Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Weave Bio raised $10M (Seed) on May 30, 2024.
  • XDemics raised $1.9M (Seed) on May 30, 2024.
  • NUTRUMAMI raised $488K (Pre-Seed) on May 30, 2024.
  • Sinopia Biosciences raised an undisclosed amount (Grant) on May 30, 2024.
  • Valar Labs, Inc. raised $22M (Series A) on May 30, 2024.
  • Aveta Biomics raised $4.5M on May 30, 2024.

Who to call at NeuroSense Therapeutics, and when

A new round usually means NeuroSense Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NeuroSense Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NeuroSense Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NeuroSense Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NeuroSense Therapeutics

Location

11 HAMENOFIM STREET, BUILDING B

Herzliya, Tel Aviv, Israel

About

NeuroSense Therapeutics is a clinical-stage biopharmaceutical company, focusing on the discovery and development of targeted innovative therapeutics for neurodegenerative diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NeuroSense Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for NeuroSense Therapeutics's next move

See what Strategic adds

NeuroSense Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.